All 34 SURI (SIMPLIFY PROPEL OPPORTUNITIES ETF) Holdings
There are 34 SURI holdings. Top 10 companies weight: 80.15%.
Total Market Cap: $29B
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (34 stocks) | -2.76% | 52.70 | 24.54 | 0.81 | +116.03% | +12.48% | 1.00 | ||||||||||
1 | PAGP | Plains Gp Holdings Lp Class A | 40.73% | $25.98 | $5.62B | Oil & Gas Midstream | Energy | N/A | 113.73 | 15.15 | 0.70 | N/A | N/A | 56 | -5.97% | $24 | +28.38% | 0.48 |
2 | ACHV | Achieve Life Sciences Inc | 11.41% | $6.50 | $174M | Biotechnology | Healthcare | -20.82% | N/A | 35.34 | N/A | N/A | N/A | 80 | +112.31% | $14 | -3.43% | N/A |
3 | MIST | Milestone Pharmaceuticals Inc | 5.24% | $1.23 | $150M | Biotechnology | Healthcare | -14.90% | N/A | N/A | N/A | N/A | N/A | 75 | +414.63% | $6.33 | -26.15% | 1.53 |
4 | DCTH | Delcath Systems Inc | 4.39% | $12.81 | $454M | Medical Devices | Healthcare | N/A | 880.89 | 25.77 | 1.60 | N/A | N/A | 80 | +68.23% | $22 | +5.96% | N/A |
5 | n/a | Achieve Life Sciences ([wts/rts]) | 3.98% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
6 | PHAT | Phathom Pharmaceuticals Inc Ordinary Shares | 3.86% | $11.25 | $878M | Biotechnology | Healthcare | -24.73% | N/A | N/A | N/A | N/A | N/A | 77 | +110.67% | $24 | -19.21% | 1.26 |
7 | CORT | Corcept Therapeutics Inc | 3.15% | $95.65 | $9.35B | Biotechnology | Healthcare | -8.23% | 212.86 | 111.11 | 0.81 | N/A | N/A | N/A | N/A | N/A | +36.32% | N/A |
8 | CLDX | Celldex Therapeutics Inc | 2.66% | $35.66 | $2.55B | Biotechnology | Healthcare | +21.48% | N/A | N/A | N/A | N/A | N/A | 76 | +63.21% | $58 | -4.26% | 1.17 |
9 | ABEO | Abeona Therapeutics Inc | 2.41% | $6.53 | $415M | Biotechnology | Healthcare | N/A | 5.39 | 526.32 | N/A | N/A | N/A | N/A | N/A | N/A | -27.68% | N/A |
10 | KYTX | Kyverna Therapeutics Inc | 2.32% | $7.48 | $471M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 83 | +306.42% | $30 | 0.00% | 1.78 |
11 | n/a | Cash | 2.05% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
12 | CMPS | Compass Pathways Plc Adr | 2.05% | $12.18 | $1.80B | Medical Care Facilities | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +100.90% | $24 | -19.88% | 1.38 |
13 | IVA | Inventiva Sa Adr | 1.77% | $4.48 | $655M | Biotechnology | Healthcare | +24.75% | N/A | N/A | N/A | N/A | N/A | 78 | +237.72% | $15 | -20.94% | 0.79 |
14 | LONA | Leonabio Inc | 1.66% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
15 | AQST | Aquestive Therapeutics Inc | 1.54% | $4.04 | $491M | Drug Manufacturers - Specialty & Generic | Healthcare | -17.65% | N/A | N/A | N/A | N/A | N/A | 80 | +120.05% | $8.89 | +1.45% | 1.37 |
16 | ZVRA | Zevra Therapeutics Inc | 1.27% | $12.45 | $766M | Biotechnology | Healthcare | N/A | 5.89 | 11.93 | 10.67 | N/A | N/A | 80 | +124.02% | $28 | +2.53% | 0.65 |
17 | ARTV | Artiva Biotherapeutics Inc | 1.21% | $10 | $303M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +258.00% | $36 | 0.00% | 1.53 |
18 | PALI | Palisade Bio Inc | 1.14% | $1.92 | $340M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +446.88% | $11 | -76.90% | N/A |
19 | n/a | Telesat Canada /telesat Llc 5.625% | 1.14% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
20 | OBIO | Orchestra Biomed Holdings Inc | 1.10% | $3.69 | $214M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +229.81% | $12 | -17.90% | 1.64 |
21 | OCUL | Ocular Therapeutix Inc | 1.07% | $8.93 | $2.18B | Biotechnology | Healthcare | -4.26% | N/A | N/A | N/A | N/A | N/A | 84 | +203.36% | $27 | -5.93% | 1.29 |
22 | n/a | Achieve Life Sciences Wts | 0.86% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
23 | EYPT | Eyepoint Inc | 0.69% | $13.05 | $1.16B | Biotechnology | Healthcare | +6.42% | N/A | 6.16 | N/A | N/A | N/A | 81 | +210.34% | $41 | +9.74% | 1.25 |
24 | UPB | Upstream Bio Inc | 0.64% | $6.98 | $396M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +447.99% | $38 | 0.00% | 1.09 |
25 | IMUX | Immunic Inc | 0.58% | $15.15 | $206M | Biotechnology | Healthcare | -24.37% | N/A | N/A | N/A | N/A | N/A | 75 | +194.85% | $45 | -30.61% | 1.28 |
26 | n/a | Akero Therapeutics Inc Cvr | 0.55% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
27 | SABS | Sab Biotherapeutics Inc | 0.51% | $3.64 | $274M | Biotechnology | Healthcare | N/A | 14.14 | N/A | N/A | N/A | N/A | 75 | +207.14% | $11 | -48.39% | 0.84 |
28 | n/a | Altimmune Inc | 0.01% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
29 | n/a | Eiger Biopharmaceuticals Inc | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
30 | n/a | Contra Chinook Therape & Npv | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
31 | n/a | Jasper Therapeutic Wts | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
32 | n/a | Wts Milestone Pharmaceuticals Inc Series B | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
33 | n/a | Wts Quoin Pharmaceuticals Ltd Series H | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
34 | n/a | Wts Tenaya Therapeutics Inc | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SURI (SIMPLIFY PROPEL OPPORTUNITIES ETF) Sector Allocation
HEALTHCARE
41.60%ENERGY
40.70%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%